Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 13,927 | 30,544 | 27,707 | 25,648 | 24,251 |
| Operating Income | -13,927 | -30,544 | -27,707 | -25,648 | -24,251 |
| Other Income | 839 | 1,131 | 1,425 | 1,610 | 1,176 |
| Pre-tax Income | -13,088 | -29,413 | -26,282 | -24,038 | -23,075 |
| Net Income Continuous | -13,088 | -29,413 | -26,282 | -24,038 | -23,075 |
| Net Income | $-13,088 | $-29,413 | $-26,282 | $-24,038 | $-23,075 |
| EPS Basic Total Ops | -0.19 | -0.43 | -0.38 | -0.35 | -0.37 |
| EPS Basic Continuous Ops | -0.19 | -0.43 | -0.38 | -0.35 | -0.37 |
| EPS Diluted Total Ops | -0.19 | -0.43 | -0.38 | -0.35 | -0.37 |
| EPS Diluted Continuous Ops | -0.19 | -0.43 | -0.38 | -0.35 | -0.37 |
| EBITDA(a) | $-13,979 | $-30,722 | $-28,148 | $-26,288 | $-24,657 |